Warning letter
Cellestis Inc: warning letter of Aug 26, 2015
FDA warning letter 458031 · Los Angeles District Office
Key facts
| Reference number | 458031 |
|---|---|
| Company | Cellestis Inc |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Aug 26, 2015 |
| Posted date | Sep 8, 2015 |
| Issuing office | Los Angeles District Office |
| Product type | Devices |
| CFR sections cited | 803, 803.3, 803.17, 803.50, 803.53, 806, 806.20, 803.50(a)(2), 803.52(e)(4), 820, 803.50(a), 803.50(b) and 1 more |
| Inspection city | Santa Clarita |
| Inspection ZIP | 91355 |
| Inspection start date | Mar 17, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: